Vis enkel innførsel

Efficacy of an infant formula manufactured from a specific protein hydrolysate derived from whey protein isolate and concentrate produced by Société des Produits Nestlé S.A. in reducing the risk of developing atopic dermatitis

dc.contributor.authorCastenmiller, Jacqueline
dc.contributor.authorHirsch-Ernst, Karen Ildico
dc.contributor.authorKearney, John
dc.contributor.authorKnutsen, Helle Katrine
dc.contributor.authorMaciuk, Alexandre
dc.contributor.authorMangelsdorf, Inge
dc.contributor.authorMcArdle, Harry J.
dc.contributor.authorNaska, Androniki
dc.contributor.authorPelaez, Carmen
dc.contributor.authorPentieva, Kristina
dc.contributor.authorSiani, Alfonso
dc.contributor.authorThies, Frank
dc.contributor.authorTsabouri, Sophia
dc.contributor.authorTurck, Dominique
dc.contributor.authorVinceti, Marco
dc.contributor.authorMarchelli, Rosangela
dc.contributor.authorvan Loveren, Henk
dc.contributor.authorDumas, Céline
dc.contributor.authorTitz, Ariane
dc.contributor.authorDe Henauw, Stefaan
dc.date.accessioned2022-08-01T06:38:21Z
dc.date.available2022-08-01T06:38:21Z
dc.date.created2021-12-01T09:52:17Z
dc.date.issued2021
dc.identifier.citationEFSA Journal. 2021, 19 (6), 1-16.
dc.identifier.issn1831-4732
dc.identifier.urihttps://hdl.handle.net/11250/3009374
dc.language.isoeng
dc.titleEfficacy of an infant formula manufactured from a specific protein hydrolysate derived from whey protein isolate and concentrate produced by Société des Produits Nestlé S.A. in reducing the risk of developing atopic dermatitis
dc.typePeer reviewed
dc.typeJournal article
dc.description.versionpublishedVersion
dc.source.pagenumber1-16
dc.source.volume19
dc.source.journalEFSA Journal
dc.source.issue6
dc.identifier.doi10.2903/j.efsa.2021.6603
dc.identifier.cristin1962433
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail
Filnavn:
Castenmiller_2021_Eff.pdf
Størrelse:
1.709Mb
Format:
PDF
Åpne

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel